252 related articles for article (PubMed ID: 11851670)
1. Detection of micrometastases in lymph nodes from patients with breast cancer.
Branagan G; Hughes D; Jeffrey M; Crane-Robinson C; Perry PM
Br J Surg; 2002 Jan; 89(1):86-9. PubMed ID: 11851670
[TBL] [Abstract][Full Text] [Related]
2. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
[TBL] [Abstract][Full Text] [Related]
3. RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes.
Ouellette RJ; Richard D; Maïcas E
Am J Clin Pathol; 2004 May; 121(5):637-43. PubMed ID: 15151203
[TBL] [Abstract][Full Text] [Related]
4. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
6. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.
Nissan A; Jager D; Roystacher M; Prus D; Peretz T; Eisenberg I; Freund HR; Scanlan M; Ritter G; Old LJ; Mitrani-Rosenbaum S
Br J Cancer; 2006 Mar; 94(5):681-5. PubMed ID: 16495929
[TBL] [Abstract][Full Text] [Related]
7. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study.
Mansel RE; Goyal A; Douglas-Jones A; Woods V; Goyal S; Monypenny I; Sweetland H; Newcombe RG; Jasani B
Breast Cancer Res Treat; 2009 Jun; 115(3):595-600. PubMed ID: 18716862
[TBL] [Abstract][Full Text] [Related]
8. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
[TBL] [Abstract][Full Text] [Related]
9. A validation study of a new molecular diagnostic assay: the Dartmouth-Hitchcock Medical Center experience with the GeneSearch BLN assay in breast sentinel lymph nodes.
Tafe LJ; Schwab MC; Lefferts JA; Wells WA; Tsongalis GJ
Exp Mol Pathol; 2010 Feb; 88(1):1-6. PubMed ID: 19840784
[TBL] [Abstract][Full Text] [Related]
10. Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma.
Matsuura K; Yamaguchi Y; Ueno H; Osaki A; Arihiro K; Toge T
Cancer; 2006 Mar; 106(6):1227-36. PubMed ID: 16475148
[TBL] [Abstract][Full Text] [Related]
11. Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes.
Martin Martinez MD; Veys I; Majjaj S; Lespagnard L; Schobbens JC; Rouas G; Filippov V; Noterman D; Hertens D; Feoli F; Bourgeois P; Durbecq V; Larsimont D; Nogaret JM
Eur J Surg Oncol; 2009 Apr; 35(4):387-92. PubMed ID: 18639429
[TBL] [Abstract][Full Text] [Related]
12. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.
Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
Am J Pathol; 1996 Feb; 148(2):649-56. PubMed ID: 8579127
[TBL] [Abstract][Full Text] [Related]
13. Transcription-reverse transcription concerted reaction and minimal residual disease in axillary sentinel nodes of breast cancer.
Ishikawa T; Miyajima E; Sasaki T; Tanabe M; Matsumoto C; Nozawa A; Kawachi K; Fukuno Y; Takeda H; Hayashi T; Onaka S; Momiyama N; Ichikawa Y; Inui K; Shimada H
Eur J Surg Oncol; 2007 May; 33(4):430-4. PubMed ID: 17101257
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients.
Lockett MA; Metcalf JS; Baron PL; O'Brien PH; Elliott BM; Robison JG; Cole DJ
Am Surg; 1998 Jun; 64(6):539-43; discussion 543-4. PubMed ID: 9619175
[TBL] [Abstract][Full Text] [Related]
15. Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer.
Motomura K; Komoike Y; Inaji H; Hasegawa Y; Kasugai T; Noguchi S; Koyama H
Br J Surg; 2002 Aug; 89(8):1032-4. PubMed ID: 12153631
[TBL] [Abstract][Full Text] [Related]
16. Additional reverse transcription-polymerase chain reaction of peripheral slices is not superior to analysis of the central slice in sentinel lymph nodes from melanoma patients.
Blaheta HJ; Roeger S; Sotlar K; Schittek B; Breuninger H; Bueltmann B; Garbe C
Br J Dermatol; 2004 Mar; 150(3):477-83. PubMed ID: 15030330
[TBL] [Abstract][Full Text] [Related]
17. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients.
Viale G; Dell'Orto P; Biasi MO; Stufano V; De Brito Lima LN; Paganelli G; Maisonneuve P; Vargo JM; Green G; Cao W; Swijter A; Mazzarol G
Ann Surg; 2008 Jan; 247(1):136-42. PubMed ID: 18156933
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer.
Barone JE; Tucker JB; Perez JM; Odom SR; Ghevariya V
Am Surg; 2005 Jan; 71(1):66-70. PubMed ID: 15757061
[TBL] [Abstract][Full Text] [Related]
20. Removal of two sentinel nodes accurately stages the axilla in breast cancer.
Kennedy RJ; Kollias J; Gill PG; Bochner M; Coventry BJ; Farshid G
Br J Surg; 2003 Nov; 90(11):1349-53. PubMed ID: 14598413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]